Home Newsfeeds Wedbush Upgrades Diebold Nixdorf to Outperform, Announces $5 Price Target

Wedbush Upgrades Diebold Nixdorf to Outperform, Announces $5 Price Target

Wedbush analyst Matt Bryson upgrades Diebold Nixdorf (NYSE:DBD) from Neutral to Outperform and announces $5 price target.

byBenzinga Newsdesk

July 8, 2022

1 minute read

Wedbush analyst Matt Bryson upgrades Diebold Nixdorf (NYSE:DBD) from Neutral to Outperform and announces $5 price target.

Alibaba, Nio Rise: Hang Seng Opens Higher On Easing China Inflation, Strong Wall Street Cues

By Bhavik Nair

December 8, 10:28 PM

Hong Kong shares opened in the green on Friday following positive cues from Wall Street where major indices gained following the release of the jobless claims data.

BABA

Conagra Brands: Q4 Earnings Insights

By Benzinga Insights

July 14, 7:51 AM

Conagra Brands (NYSE:CAG) reported its Q4 earnings results on Thursday, July 14, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

CAG

News

What’s Going On With Tesla Stock Today

By Henry Khederian

March 31, 11:34 AM

Tesla Inc (NASDAQ: TSLA) shares are trading higher by 3.37% to $201.90 Friday morning. Strength may be related to the company's upcoming first-quarter deliveries report, which is expected Sunday.

TSLA

Humana Expects To Report About $26.09 In Adjusted EPS For Year Ended December 31, 2023 Versus Prior Guidance Of At Least $28.25 And Consensus Of $28.30

By Benzinga Newsdesk

January 18, 7:46 AM

As shared on the Company’s third quarter 2023 earnings call on November 1, 2023, the Company anticipated the higher level of medical utilization experienced during the third quarter in its

HUM

Wedbush Upgrades Diebold Nixdorf to Outperform, Announces $5 Price Target

Related Posts

Alibaba, Nio Rise: Hang Seng Opens Higher On Easing China Inflation, Strong Wall Street Cues

Conagra Brands: Q4 Earnings Insights

What’s Going On With Tesla Stock Today

Humana Expects To Report About $26.09 In Adjusted EPS For Year Ended December 31, 2023 Versus Prior Guidance Of At Least $28.25 And Consensus Of $28.30